Barclays PLC Penumbra Inc Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Penumbra Inc stock. As of the latest transaction made, Barclays PLC holds 15,466 shares of PEN stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,466
Previous 37,766
59.05%
Holding current value
$2.96 Million
Previous $8.43 Million
66.96%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PEN
# of Institutions
383Shares Held
29.6MCall Options Held
285KPut Options Held
168K-
Black Rock Inc. New York, NY4.26MShares$815 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.7MShares$708 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$580 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.28MShares$246 Million1.46% of portfolio
-
State Street Corp Boston, MA1.23MShares$236 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $7.26B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...